Extracorporeal CO2 removal devices are emerging as an important adjunct in advanced respiratory support, particularly for patients with acute hypercapnic respiratory failure, acute exacerbations of chronic obstructive pulmonary disease, and acute respiratory distress syndrome where conventional ventilation can contribute to lung injury. These systems remove carbon dioxide through an extracorporeal blood circuit using membrane gas exchange, enabling clinicians to reduce ventilatory intensity and support lung-protective or ultra-protective ventilation strategies. Clinical relevance is reinforced by the global burden of COPD, which the World Health Organization identifies as a leading cause of death worldwide, and by the continuing need to manage severe respiratory infections, refractory hypercapnia, and prolonged mechanical ventilation in intensive care units. The sector is shaped by rising clinical interest in lower-flow extracorporeal support, improvements in hemocompatible membranes, anticoagulation management, vascular access, and critical care workflow integration. Adoption remains highly dependent on trained multidisciplinary teams, reimbursement structures, safety evidence, and hospital infrastructure; however, extracorporeal carbon dioxide removal continues to attract attention as health systems seek more precise, less injurious respiratory support options for complex critical care populations.

Transformative Shifts in the Extracorporeal CO2 Removal Landscape

The extracorporeal CO2 removal devices landscape is being transformed by a shift from rescue-oriented extracorporeal support toward targeted respiratory management designed to reduce ventilator-associated lung injury. Device innovation is moving toward lower priming volumes, improved membrane oxygenator performance, simplified circuits, pressure and flow monitoring, and enhanced biocompatibility to reduce clotting, bleeding, hemolysis, and inflammatory complications. Clinical protocols are also evolving as intensive care units refine patient selection, timing of intervention, anticoagulation strategies, vascular access practices, escalation criteria, and weaning pathways. Another notable shift is the convergence of respiratory care, nephrology, perfusion, and extracorporeal life support expertise, as some platforms and care models align with familiar renal replacement therapy workflows. Regulatory scrutiny and evidence generation are becoming more rigorous, with hospitals demanding outcomes data, usability evidence, human factors validation, and clear risk-benefit profiles before broad deployment. At the same time, pandemic-era investments in critical care infrastructure have increased awareness of extracorporeal technologies, although adoption still varies widely by region, training availability, reimbursement support, and institutional experience.

Cumulative Impact of Artificial Intelligence on Extracorporeal CO2 Removal

Artificial intelligence is beginning to influence extracorporeal CO2 removal through decision support, device monitoring, predictive analytics, and workflow optimization rather than replacing clinician judgment. In critical care environments, AI-enabled models can help identify patients at risk of ventilator-induced lung injury, refractory hypercapnia, prolonged mechanical ventilation, or rapid acid-base deterioration by analyzing blood gases, ventilator settings, hemodynamics, laboratory trends, imaging outputs, and comorbidity profiles. When integrated with extracorporeal platforms and hospital information systems, advanced analytics may support earlier recognition of circuit clotting risk, membrane performance decline, anticoagulation instability, pressure changes, gas exchange inefficiency, or hemodynamic deterioration. AI can also enhance protocol adherence by flagging deviations in sweep gas settings, blood flow parameters, arterial carbon dioxide levels, acid-base status, and lung-protective ventilation targets. However, the cumulative impact depends on validated clinical datasets, interoperability, transparent algorithms, cybersecurity safeguards, clinician oversight, and careful mitigation of bias across diverse patient populations. The most immediate value is expected in augmenting intensivists, perfusionists, respiratory therapists, nephrologists, and nurses with real-time insights that improve safety, reduce cognitive burden, and standardize complex extracorporeal respiratory support practices.

Key Regional Insights Across Asia-Pacific, North America, Latin America, Europe, the Middle East, and Africa

Asia-Pacific is characterized by a substantial burden of chronic respiratory disease, dense urban populations exposed to air pollution, and expanding tertiary care infrastructure, creating strong clinical relevance for extracorporeal CO2 removal in advanced hospitals, particularly in China, Japan, South Korea, Australia, and India. North America benefits from mature intensive care networks, established extracorporeal life support expertise, academic critical care programs, and a regulatory environment that emphasizes safety evidence, quality systems, and clinical performance, supporting structured adoption in specialized centers. Latin America shows selective uptake concentrated in major metropolitan hospitals, where respiratory disease burden and critical care modernization coexist with constraints related to reimbursement, specialist training, biomedical engineering support, and access to disposable consumables. Europe is supported by strong critical care research networks, established respiratory medicine expertise, and harmonized medical device regulations that increase emphasis on clinical evaluation, post-market surveillance, risk management, and quality management. The Middle East is advancing through investment in high-acuity hospital infrastructure, medical tourism hubs, and government-backed healthcare modernization, with adoption most visible in advanced tertiary and quaternary care institutions. Africa remains highly heterogeneous, with limited access outside major referral centers; however, the growing burden of respiratory infections, COPD, tuberculosis-associated lung disease, and critical illness underscores the need for scalable training, biomedical engineering capability, oxygen and blood gas infrastructure, and reliable supply chains before extracorporeal CO2 removal can expand meaningfully.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

Within ASEAN, the relevance of extracorporeal CO2 removal is linked to increasing critical care investment, rising noncommunicable respiratory disease, persistent air quality challenges, and uneven access between advanced urban hospitals and resource-constrained settings. GCC countries are supported by high healthcare expenditure, modern hospital infrastructure, and strategic investment in specialized intensive care services, making the group comparatively well positioned for advanced extracorporeal respiratory support where trained multidisciplinary teams are available. The European Union provides a structured environment for device quality, clinical evidence, and cross-border research collaboration, with adoption shaped by medical device regulation, health technology assessment, procurement scrutiny, and hospital-level cost-effectiveness evaluation. BRICS countries combine large respiratory disease burdens with expanding tertiary care capacity, but adoption varies significantly due to differences in reimbursement, local manufacturing capability, specialist training, regulatory pathways, and public-sector procurement. G7 countries generally demonstrate stronger readiness because of advanced ICU infrastructure, established clinical research ecosystems, respiratory medicine expertise, and greater availability of multidisciplinary extracorporeal teams, although payer evaluation and safety evidence remain decisive. NATO member states overlap substantially with high-income healthcare systems and maintain advanced critical care capabilities, while emergency preparedness, trauma care, and military medicine priorities may further reinforce interest in portable, reliable, and rapidly deployable extracorporeal technologies for severe respiratory failure scenarios.

Key Country Insights Across Major Extracorporeal CO2 Removal Markets

The United States demonstrates strong relevance for extracorporeal CO2 removal due to its advanced critical care ecosystem, high COPD burden, large network of academic hospitals, and concentration of specialized centers experienced in extracorporeal life support, while Canada's adoption is influenced by publicly funded healthcare evaluation, regional referral networks, and emphasis on evidence-based ICU practice. Mexico and Brazil face significant respiratory disease burdens and growing tertiary care capabilities, but access is more concentrated in high-complexity hospitals where training, reimbursement, referral pathways, and consumable supply determine practical deployment. In Europe, the United Kingdom, Germany, France, Italy, and Spain have well-developed intensive care and respiratory medicine systems, with Germany and France particularly associated with strong hospital infrastructure and clinical research capacity, while the United Kingdom emphasizes guideline-driven adoption, national clinical governance, and health technology assessment. Russia has advanced tertiary medical centers capable of complex critical care, although geographic scale and uneven infrastructure influence availability. China is expanding critical care capacity rapidly and faces a large COPD and air pollution-related respiratory burden, creating strong clinical rationale in major hospitals; India combines a high respiratory disease burden with uneven ICU access, making affordability, training, and scalable service models critical. Japan, South Korea, and Australia have mature hospital systems, strong biomedical standards, experienced critical care communities, and established approaches to high-acuity respiratory support, supporting selective adoption in specialized settings where patient selection, anticoagulation management, and safety protocols are well established.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize robust clinical evidence, practical usability, and safety-centered design to accelerate responsible adoption of extracorporeal CO2 removal devices. Product development should focus on reducing bleeding and thrombosis risks, simplifying circuit setup, improving membrane durability, minimizing blood trauma, strengthening pressure and flow monitoring, and enabling integration with ICU information systems and ventilator data streams. Commercial strategies should be tailored to hospital readiness rather than broad deployment, targeting specialized intensive care centers with trained respiratory, perfusion, nephrology, vascular access, and extracorporeal life support teams. Education programs should include simulation-based training, anticoagulation protocols, cannulation and vascular access guidance, troubleshooting pathways, alarm management, and multidisciplinary competency frameworks. Leaders should also invest in real-world evidence registries, post-market surveillance, human factors studies, and interoperable data capture to demonstrate safety, clinical utility, and workflow value. In emerging regions, partnerships with hospitals, professional societies, and public health stakeholders can help address training gaps, maintenance capability, consumable availability, and supply-chain reliability. Clear positioning as an adjunct to lung-protective ventilation, rather than a universal replacement for conventional care, will support clinically credible messaging and sustainable adoption.

Research Methodology

The research methodology for evaluating extracorporeal CO2 removal devices relies on triangulation of verified secondary sources, clinical literature, regulatory documentation, hospital practice patterns, and expert-informed interpretation of critical care trends. Evidence inputs include peer-reviewed studies on extracorporeal carbon dioxide removal, respiratory failure management, COPD and ARDS care, mechanical ventilation strategies, anticoagulation complications, device safety, membrane gas exchange, and ICU workflow integration. Public health data from recognized national and international agencies are used to contextualize respiratory disease burden, critical care needs, air pollution exposure, demographic pressures, and regional healthcare capacity. Regulatory and standards-based sources inform analysis of device approval pathways, quality requirements, clinical evaluation expectations, risk management, usability engineering, and post-market responsibilities. Insights are validated by comparing findings across multiple source categories, including clinical guidelines, systematic reviews, registry-based observations, health system reports, medical technology policy documents, and critical care society publications. The methodology deliberately avoids market sizing, market share calculations, or forecasting and instead focuses on evidence-backed qualitative assessment of technology adoption drivers, barriers, regional readiness, and strategic implications for stakeholders.

Conclusion

Extracorporeal CO2 removal devices occupy a strategically important position in the evolution of advanced respiratory support, particularly as critical care teams seek to reduce ventilator-induced injury while managing severe hypercapnia and complex respiratory failure. The field is advancing through improvements in membrane technology, circuit design, monitoring, clinical protocols, vascular access, anticoagulation practice, and multidisciplinary training, while artificial intelligence offers additional potential to strengthen patient selection, safety surveillance, and operational consistency. Regional adoption is shaped less by disease burden alone and more by the availability of specialized ICU infrastructure, reimbursement clarity, regulatory confidence, reliable consumable supply, and experienced clinical teams. Countries and groups with established critical care networks are better positioned for selective implementation, while emerging settings require scalable training, service models, biomedical engineering support, and supply-chain resilience. For industry participants, long-term success will depend on generating credible clinical evidence, designing safer and simpler systems, and aligning technology with real-world intensive care workflows. As hospitals refine lung-protective strategies, extracorporeal CO2 removal is expected to remain a high-interest technology within precision critical care and advanced respiratory medicine.

Product Code: MRR-F927BA462E0F

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
4.3. Market Dynamics
- 4.3.1. Key Drivers
- 4.3.2. Key Restraints
- 4.3.3. Key Opportunities
- 4.3.4. Key Challenges
4.4. Porter's Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
- 4.6.1. Near-Term Market Outlook (0-2 Years)
- 4.6.2. Medium-Term Market Outlook (3-5 Years)
- 4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Extracorporeal CO2 Removal Devices Market, by Product

7.1. Introduction
7.2. Membrane Lung Systems
- 7.2.1. Low-Flow Cartridges
- 7.2.2. High-Flux Cartridges
7.3. Modular ECCO2R Kits
- 7.3.1. Renal Platform Adapters
- 7.3.2. ECMO Platform Adapters
7.4. Control Consoles
7.5. Disposable Treatment Sets

8. Extracorporeal CO2 Removal Devices Market, by Technology

8.1. Introduction
8.2. Pump-Driven Venovenous
- 8.2.1. Dual-Lumen Venous
- 8.2.2. Single-Lumen Venous
8.3. Arteriovenous Pumpless
8.4. Hemodialysis-Based Removal
8.5. Hybrid Gas Exchange

9. Extracorporeal CO2 Removal Devices Market, by Capacity Level

9.1. Introduction
9.2. Low-Flow Removal
9.3. Moderate-Flow Removal
9.4. High-Flow Removal

10. Extracorporeal CO2 Removal Devices Market, by Mode of Operation

10.1. Introduction
10.2. Automated Systems
10.3. Manual Systems

11. Extracorporeal CO2 Removal Devices Market, by Application

11.1. Introduction
11.2. Acute Respiratory Distress Syndrome
11.3. Bridge to Lung Transplant
11.4. Chronic Obstructive Pulmonary Disease
11.5. Postoperative Respiratory Support
11.6. Hypercapnic Respiratory Failure

12. Extracorporeal CO2 Removal Devices Market, by End User

12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Care Settings
12.4. Hospitals
12.5. Specialty Clinics

13. Extracorporeal CO2 Removal Devices Market, by Region

13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa

14. Extracorporeal CO2 Removal Devices Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Extracorporeal CO2 Removal Devices Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. Competitive Landscape

16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
- 16.3.1. Concentration Ratio (CR)
- 16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025

17. Company Profiles

17.1. Aferetica Srl
17.2. Baxter International Inc.
17.3. Braile Biomedica S.A.
17.4. Chalice Medical Ltd
17.5. Dragerwerk AG & Co. KGaA
17.6. Estor S.p.A
17.7. Fresenius Medical Care AG
17.8. Getinge AB
17.9. Inspira-Technologies OXY B.H.N. LTD
17.10. Koninklijke Philips N.V.
17.11. LivaNova PLC
17.12. Medica S.p.A
17.13. MicroPort Scientific Corporation
17.14. Nikkiso Co., Ltd.
17.15. NovaLung GmbH
17.16. Spectrum Medical Ltd
17.17. Terumo Corporation
17.18. WEGO Group Co., Ltd.
17.19. X-COR Therapeutics

Product Code: MRR-F927BA462E0F

LIST OF FIGURES

FIGURE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2025 VS 2032 (%)
FIGURE 11. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

TABLE 1. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MEMBRANE LUNG SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LOW-FLOW CARTRIDGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HIGH-FLUX CARTRIDGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MODULAR ECCO2R KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RENAL PLATFORM ADAPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ECMO PLATFORM ADAPTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTROL CONSOLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTROL CONSOLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CONTROL CONSOLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DISPOSABLE TREATMENT SETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PUMP-DRIVEN VENOVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DUAL-LUMEN VENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SINGLE-LUMEN VENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ARTERIOVENOUS PUMPLESS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HEMODIALYSIS-BASED REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HYBRID GAS EXCHANGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL LOW-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MODERATE-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HIGH-FLOW REMOVAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MANUAL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ACUTE RESPIRATORY DISTRESS SYNDROME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BRIDGE TO LUNG TRANSPLANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL POSTOPERATIVE RESPIRATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HYPERCAPNIC RESPIRATORY FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 126. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 127. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 128. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 131. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 132. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 146. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 147. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 148. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 150. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 151. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 152. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. AFRICA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 157. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 158. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 159. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 161. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 162. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 163. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 164. ASEAN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 167. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 168. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 169. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 171. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 172. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 173. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. GCC EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 187. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 188. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 189. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 191. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 192. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 193. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 194. BRICS EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 198. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 199. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 200. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 201. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 202. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 203. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. G7 EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 207. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 208. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 209. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 211. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 212. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 213. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. NATO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 228. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 229. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 230. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 231. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 232. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 233. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 234. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 235. CANADA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 236. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 237. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 238. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 239. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 240. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 242. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 243. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 244. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. MEXICO EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 247. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 248. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 249. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 250. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 252. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 253. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 254. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 255. BRAZIL EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 263. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 267. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 268. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 269. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 270. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 271. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 272. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 273. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 274. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 275. GERMANY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 276. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 278. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 279. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 280. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 281. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 282. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 283. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 284. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 285. FRANCE EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 287. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 288. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 289. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 290. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 291. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 292. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 293. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 294. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 295. RUSSIA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 296. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 298. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 299. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 300. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 302. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 303. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 304. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 305. ITALY EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 307. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 308. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MEMBRANE LUNG SYSTEMS, 2018-2032 (USD MILLION)
TABLE 309. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODULAR ECCO2R KITS, 2018-2032 (USD MILLION)
TABLE 310. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 311. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PUMP-DRIVEN VENOVENOUS, 2018-2032 (USD MILLION)
TABLE 312. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY CAPACITY LEVEL, 2018-2032 (USD MILLION)
TABLE 313. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
TABLE 314. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. SPAIN EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 316. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 317. CHINA EXTRACORPOREAL CO2 REMOVAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ

SELECT AN OPTION